Tuesday, June 6, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

Army Opens New Proteomics Core Lab for CBRNE Research

by Global Biodefense Staff
November 29, 2012

The U.S. Army Edgewood Chemical Biological Center (ECBC), and the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD) last month officially opened a new Proteomics Core Facility at Aberdeen Proving Ground, MD. 

The organizations collaborated to design a shared working space to meet expanding requirements for proteomics and genomics research at each institution. 

“Rather than duplicate the capabilities, why not build them in one joint facility?” said Jennifer Sekowski, Ph.D., Molecular Toxicologist and ECBC lead for standing up the Proteomics Core Facility. “Having a combined Genomics and Proteomics Core now allows us to more easily share our resources, provide new training opportunities, and expand the amount and type of research we both can do.” (Source: U.S. Army)

The facility will support biological research into a variety of Chemical, Biological, Radiological, Nuclear and high-yield Explosives (CBRNE) issues. Newly-added equipment will help advance research utilizing mass spectrometry-based proteomics, high content image analysis of cells and tissues, whole genomic sequencing and finishing, expression analysis and microRNA.

The Proteomics Core Facility is part of Aberdeen’s state-of-the-art McNamara Life Sciences Research Facility which also houses ECBC’s High-Containment Biosafety Level 3 (BSL-3) Laboratory and Special Containment Facility.

Tags: BiosafetyECBCUSAMRICD

Related Posts

Medical Countermeasures

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Load More

Latest News

Vials of finished vaccines

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

April 26, 2023
Biodefense Headlines – 25 April 2023

Biodefense Headlines – 25 April 2023

April 25, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2023 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2023 Stemar Media Group LLC